Buprenorphine
Product Images NDC 68071-2592

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 68071-2592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2592 3)

NuCare Pharmaceuticals, Inc. is the manufacturer of Buprenorphine 8mg Sublingual tablets, with a lot number of 000000 and expiration date of 00-00. Each tablet contains 8.64mg of Buprenorphine HCI, equivalent to 8mg of Buprenorphine. Patients are advised to see the manufacturer's label for a full list of ingredients and to seek medical advice regarding side effects. This warning is mentioned on the label: "keep out of reach of children store at controlled temperature 68-77°F."*

FDA Label Image

Chemical Structure (Buprenorphine 01)

FDA Label Image

Image (Buprenorphine 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.